Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA ® (narsoplimab-wuug) for the treatment of hematopoietic stem cell ...

Omeros Corporation (NASDAQ: OMER) today announced a revised date for its conference call to discuss the recent FDA approval of YARTEMLEA ® (narsoplimab-wuug), the first and only therapy indicated for ...

YORKSHIRE are putting together a five-year plan to build on what Colin Graves has described as “a hell of a year”, one in which the club’s finances have been revolutionised by the sale of The Hundred ...

Following changes to immigration in Ontario, some with hopes of becoming Canadian permanent residents are navigating a system that's in flux — and they're concerned they'll be left behind. Seeing it ...